|
|
||||||||



* Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana 70808;
Mount Sinai Medical School, New York, New York 10029; and
Texas A&M University, College Station, Texas 77843
Lamprey gonadotropin-releasing hormone-III (l-GnRH-III), the putative follicle-stimulating hormone (FSH)-releasing factor (FSHRF), exerts a preferential FSH-releasing activity in rats both in vitro and in vivo. To test the hypothesis that l-GnRH-III acts on its own receptors to stimulate gonadotropin release, the functional activity of this peptide at mammalian (m) leutinizing hormone (LH)RH receptors transfected to COS cells was tested. l-GnRH-III activated m-LHRH receptors only at a minimal effective concentration (MEC) of 10-6 M, whereas m-LHRH was active at a MEC of 10-9 M, at least 1,000 times less than that required for l-GnRH-III. In 4-day monolayer cultured cells, l-GnRH-III was similarly extremely weak in releasing either LH or FSH, and, in fact, it released LH at a lower concentration (10-7 M) than that required for FSH release (10-6 M). In this assay, m-LHRH released both FSH and LH significantly at the lowest concentration tested (10-10 M). On the other hand, l-GnRH-III had a high potency to selectively release FSH and not LH from hemipituitaries of male rats. The results suggest that the cultured cells were devoid of FSHRF receptors, thereby resulting in a pattern of FSH and LH release caused by the LHRH receptor. On the other hand, the putative FSH-releasing factor receptor accounts for the selective FSH release by l-GnRH-III when tested on hemipituitaries. Removal of calcium from the medium plus the addition of EGTA, a calcium chelator, suppressed the release of gonadotropins induced by either l-GnRH-III or LHRH, indicating that calcium is required for the action of either peptide. Previous results showed that sodium nitroprusside, a releaser of nitric oxide (NO), causes the release of both FSH and LH from hemipituitaries incubated in vitro. In the present experiments, a competitive inhibitor of NO synthase, L-NG-monomethyl-L-arginine (300 µM) blocked the action of l-GnRH-III or partially purified FSHRF. The results indicate that l-GnRH-III and FSHRF act on putative FSHRF receptors by a calcium-dependent NO pathway.
Key Words: m-LHRH receptors FSHRF receptors NO synthase cGMP
This article has been cited by other articles:
![]() |
A. Bowen, S. Khan, L. Berghman, J. D. Kirby, R .P. Wettemann, and J. A. Vizcarra Immunization of pigs against chicken gonadotropin-releasing hormone-II and lamprey gonadotropin-releasing hormone-III: Effects on gonadotropin secretion and testicular function J Anim Sci, November 1, 2006; 84(11): 2990 - 2999. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Guillemin Hypothalamic hormones a.k.a. hypothalamic releasing factors J. Endocrinol., January 1, 2005; 184(1): 11 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Amstalden, D A Zieba, M R Garcia, R L Stanko, T H Welsh Jr, W H Hansel, and G L Williams Evidence that lamprey GnRH-III does not release FSH selectively in cattle Reproduction, January 1, 2004; 127(1): 35 - 43. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |